Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for EWTX

Stock Name	Edgewise Therapeutics Inc
Ticker	EWTX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US28036F1057

Show aggregate EWTX holdings

News associated with EWTX

JPMorgan Chase & Co. Lowers Edgewise Therapeutics (NASDAQ:EWTX) Price Target to $30.00: Edgewise Therapeutics (NASDAQ:EWTX – Free Report) had its price target trimmed by JPMorgan Chase & Co. from $40.00 to $30.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has an overweight rating on the stock. A number of other research analysts have also issued reports on EWTX. Royal Bank Of […] - 2025-08-20 03:02:43
TD Asset Management Inc Invests $730,000 in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): TD Asset Management Inc acquired a new position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 33,200 shares of the company’s stock, valued at approximately $730,000. Several other institutional investors also recently modified […] - 2025-08-05 04:37:18
Arizona State Retirement System Increases Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Arizona State Retirement System raised its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 12.3% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 12,201 shares of the company’s stock after purchasing an additional 1,338 shares during the quarter. Arizona […] - 2025-07-23 05:44:46
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Acquired by Arizona State Retirement System: Arizona State Retirement System boosted its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 12.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 12,201 shares of the company’s stock after acquiring an additional 1,338 shares during the period. Arizona […] - 2025-07-23 04:52:54
Brokerages Set Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Price Target at $40.00: Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the ten research firms that are presently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1 year […] - 2025-07-08 02:38:53
HC Wainwright Begins Coverage on Edgewise Therapeutics (NASDAQ:EWTX): HC Wainwright began coverage on shares of Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report) in a note issued to investors on Monday, MarketBeat reports. The firm set a “buy” rating and a $42.00 price target on the stock. HC Wainwright’s price objective would suggest a potential upside of 227.61% from the company’s previous close. Several […] - 2025-07-02 02:34:45
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $39.78 Consensus PT from Brokerages: Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) has earned a consensus rating of “Moderate Buy” from the nine brokerages that are currently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average twelve-month price target among brokers […] - 2025-06-13 02:14:54
Squarepoint Ops LLC Purchases 9,729 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Squarepoint Ops LLC lifted its position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 58.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 26,358 shares of the company’s stock after buying an additional 9,729 shares during the quarter. Squarepoint Ops LLC’s […] - 2025-06-03 05:04:51
Two Sigma Investments LP Reduces Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Two Sigma Investments LP lowered its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 49.6% in the 4th quarter, HoldingsChannel reports. The fund owned 131,667 shares of the company’s stock after selling 129,791 shares during the period. Two Sigma Investments LP’s holdings in Edgewise Therapeutics were worth $3,516,000 at the end of the […] - 2025-05-30 05:27:09
Nuveen Asset Management LLC Raises Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Nuveen Asset Management LLC raised its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 58.6% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 428,858 shares of the company’s stock after purchasing an additional 158,452 shares during the quarter. Nuveen Asset Management LLC’s holdings in Edgewise Therapeutics were worth $11,451,000 at […] - 2025-05-28 04:58:59
BNP Paribas Financial Markets Buys Shares of 33,082 Edgewise Therapeutics, Inc. (NASDAQ:EWTX): BNP Paribas Financial Markets purchased a new position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) during the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 33,082 shares of the company’s stock, valued at approximately $883,000. Several other large investors have also recently made changes to their positions in EWTX. First Light Asset Management […] - 2025-05-22 04:38:48
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Average Recommendation of “Moderate Buy” from Brokerages: Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the nine brokerages that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month […] - 2025-05-16 02:58:59
The Manufacturers Life Insurance Company Has $1.07 Million Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): The Manufacturers Life Insurance Company increased its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 4.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 40,170 shares of the company’s stock after purchasing an additional 1,760 shares during the period. The Manufacturers […] - 2025-05-14 04:46:53
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Bought by Price T Rowe Associates Inc. MD: Price T Rowe Associates Inc. MD boosted its stake in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 22.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 29,050 shares of the company’s stock after purchasing an additional 5,242 shares […] - 2025-05-12 05:18:50
Dimensional Fund Advisors LP Grows Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Dimensional Fund Advisors LP grew its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 0.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 729,923 shares of the company’s stock after buying an additional 3,052 shares during […] - 2025-05-08 04:50:47
Envestnet Asset Management Inc. Grows Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Envestnet Asset Management Inc. increased its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 32.0% in the 4th quarter, HoldingsChannel reports. The fund owned 14,678 shares of the company’s stock after purchasing an additional 3,561 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Edgewise Therapeutics were worth $392,000 at the end […] - 2025-05-06 04:24:53
Edgewise Therapeutics (NASDAQ:EWTX) Earns Buy Rating from Analysts at Guggenheim: Guggenheim initiated coverage on shares of Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report) in a research report issued to clients and investors on Wednesday, Marketbeat.com reports. The firm set a “buy” rating and a $41.00 price target on the stock. Guggenheim’s price target suggests a potential upside of 145.80% from the stock’s current price. Other […] - 2025-05-02 05:02:53
Invesco Ltd. Sells 21,341 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Invesco Ltd. lowered its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 32.9% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 43,435 shares of the company’s stock after selling 21,341 shares during the quarter. Invesco Ltd.’s holdings in Edgewise Therapeutics were worth $1,160,000 as of its most recent […] - 2025-05-02 04:26:44
Marshall Wace LLP Sells 547,672 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Marshall Wace LLP reduced its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 94.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 29,893 shares of the company’s stock after selling 547,672 shares during the period. […] - 2025-05-01 05:43:00
Barclays PLC Has $3.57 Million Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Barclays PLC grew its position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 12.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 133,657 shares of the company’s stock after purchasing an additional 14,307 shares during the quarter. Barclays PLC’s holdings in Edgewise Therapeutics were worth $3,568,000 at the end of the […] - 2025-04-29 05:08:56
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $40.38 Average PT from Brokerages: Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eight brokerages that are currently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month […] - 2025-04-24 02:10:55
Edgewise Therapeutics (NASDAQ:EWTX) Receives “Outperform” Rating from Wedbush: Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report)‘s stock had its “outperform” rating reissued by Wedbush in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $43.00 price objective on the stock. Wedbush’s price target points to a potential upside of 217.81% from the company’s previous close. Several other research […] - 2025-04-23 03:00:59
Alliancebernstein L.P. Raises Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Alliancebernstein L.P. increased its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 1.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 77,260 shares of the company’s stock after purchasing an additional 1,300 shares during the period. Alliancebernstein L.P.’s holdings […] - 2025-04-17 04:30:59
Geode Capital Management LLC Increases Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Geode Capital Management LLC grew its holdings in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 0.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,600,571 shares of the company’s stock after purchasing an additional 1,036 shares during the quarter. Geode […] - 2025-04-15 05:08:57
Orion Portfolio Solutions LLC Decreases Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Orion Portfolio Solutions LLC decreased its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 8.3% during the 4th quarter, Holdings Channel.com reports. The fund owned 11,928 shares of the company’s stock after selling 1,083 shares during the period. Orion Portfolio Solutions LLC’s holdings in Edgewise Therapeutics were worth $318,000 at the […] - 2025-04-10 05:38:57
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Director Acquires $10,000,000.23 in Stock: Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) Director Orbimed Advisors Llc acquired 496,771 shares of Edgewise Therapeutics stock in a transaction that occurred on Thursday, April 3rd. The stock was acquired at an average price of $20.13 per share, with a total value of $10,000,000.23. Following the completion of the acquisition, the director now […] - 2025-04-07 06:28:50
Scotiabank Downgrades Edgewise Therapeutics (NASDAQ:EWTX) to Sector Perform: Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report) was downgraded by research analysts at Scotiabank from a “sector outperform” rating to a “sector perform” rating in a research report issued on Wednesday, Marketbeat.com reports. They currently have a $14.00 target price on the stock, down from their prior target price of $50.00. Scotiabank’s price target would […] - 2025-04-04 03:14:47
Noteworthy Wednesday Option Activity: EWTX, PACK, ORCL: Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Edgewise Therapeutics Inc (Symbol: EWTX), where a total of 15,988 contracts have traded so far, representing approximately 1.6 million underlying shares. That amounts to - 2025-04-02 16:27:28
Teacher Retirement System of Texas Has $298,000 Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Teacher Retirement System of Texas raised its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 18.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,143 shares of the company’s stock after purchasing an […] - 2025-04-02 04:42:47
Quantbot Technologies LP Purchases Shares of 3,855 Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Quantbot Technologies LP purchased a new stake in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund purchased 3,855 shares of the company’s stock, valued at approximately $103,000. Other institutional investors have also recently made changes to their positions […] - 2025-04-01 04:54:48

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc EWTX holdings

Date	Number of EWTX Shares Held	Base Market Value of EWTX Shares	Local Market Value of EWTX Shares	Change in EWTX Shares Held	Change in EWTX Base Value	Current Price per EWTX Share Held	Previous Price per EWTX Share Held
2025-12-11 (Thursday)	21,473	USD 503,112	USD 503,112	0	USD -6,657	USD 23.43	USD 23.74
2025-12-10 (Wednesday)	21,473	USD 509,769	USD 509,769	0	USD 8,589	USD 23.74	USD 23.34
2025-12-09 (Tuesday)	21,473	USD 501,180	USD 501,180	0	USD -4,724	USD 23.34	USD 23.56
2025-12-08 (Monday)	21,473	USD 505,904	USD 505,904	0	USD -644	USD 23.56	USD 23.59
2025-12-05 (Friday)	21,473	USD 506,548	USD 506,548	0	USD -2,577	USD 23.59	USD 23.71
2025-12-04 (Thursday)	21,473	USD 509,125	USD 509,125	0	USD 8,375	USD 23.71	USD 23.32
2025-12-03 (Wednesday)	21,473	USD 500,750	USD 500,750	-375	USD -1,317	USD 23.32	USD 22.98
2025-12-02 (Tuesday)	21,848	USD 502,067	USD 502,067	150	USD -46,241	USD 22.98	USD 25.27
2025-12-01 (Monday)	21,698	USD 548,308	USD 548,308	0	USD -16,708	USD 25.27	USD 26.04
2025-11-28 (Friday)	21,698	USD 565,016	USD 565,016	0	USD 11,283	USD 26.04	USD 25.52
2025-11-27 (Thursday)	21,698	USD 553,733	USD 553,733	0	USD 0	USD 25.52	USD 25.52
2025-11-26 (Wednesday)	21,698	USD 553,733	USD 553,733	0	USD 31,679	USD 25.52	USD 24.06

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EWTX by Blackrock for IE00B3VWM098

Show aggregate share trades of EWTX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-03 SELL -375 23.480 22.510 22.607 USD -8,478 20.95 Loss of -621 on sale
2025-12-02 BUY 150 25.655 22.950 23.221 USD 3,483 20.94
2025-11-25 SELL -225 24.145 23.280 23.367 USD -5,257 20.84 Loss of -570 on sale
2025-11-24 SELL -225 23.860 22.670 22.789 USD -5,128 20.82 Loss of -443 on sale
2025-11-17 SELL -825 22.890 22.070 22.152 USD -18,275 20.78 Loss of -1,129 on sale
2025-11-12 SELL -75 21.570 20.340 20.463 USD -1,535 20.77 Profit of 23 on sale
2025-11-06 SELL -75 18.260 17.070 17.189 USD -1,289 20.82 Profit of 272 on sale
2025-11-05 SELL -760 17.520 16.820 16.890 USD -12,836 20.84 Profit of 3,001 on sale
2025-11-04 SELL -152 17.885 16.990 17.079 USD -2,596 20.86 Profit of 574 on sale
2025-11-03 SELL -152 18.610 17.635 17.733 USD -2,695 20.87 Profit of 477 on sale
2025-10-28 BUY 228 16.420 16.620 16.600 USD 3,785 20.95
2025-10-24 SELL -76 15.180 15.320 15.306 USD -1,163 21.01 Profit of 433 on sale
2025-10-15 BUY 456 15.620 15.810 15.791 USD 7,201 21.23
2025-10-02 BUY 76 15.000 15.620 15.558 USD 1,182 21.30
2025-09-30 BUY 150 16.220 16.370 16.355 USD 2,453 21.37
2025-08-21 SELL -75 14.620 14.740 14.728 USD -1,105 21.56 Profit of 512 on sale
2025-07-31 BUY 225 14.260 14.790 14.737 USD 3,316 21.65
2025-06-30 SELL -150 13.110 13.840 13.767 USD -2,065 22.70 Profit of 1,340 on sale
2025-06-25 SELL -75 14.330 14.780 14.735 USD -1,105 22.90 Profit of 612 on sale
2025-06-20 SELL -150 14.300 14.655 14.619 USD -2,193 23.08 Profit of 1,269 on sale
2025-05-23 BUY 75 14.210 14.310 14.300 USD 1,073 24.47
2025-05-19 SELL -75 14.790 14.920 14.907 USD -1,118 24.81 Profit of 742 on sale
2025-05-15 SELL -225 14.450 14.640 14.621 USD -3,290 24.99 Profit of 2,332 on sale
2025-05-12 SELL -75 14.820 15.820 15.720 USD -1,179 25.26 Profit of 716 on sale
2025-05-09 SELL -75 14.580 15.550 15.453 USD -1,159 25.36 Profit of 743 on sale
2025-04-30 SELL -75 16.400 16.540 16.526 USD -1,239 26.01 Profit of 712 on sale
2025-04-24 SELL -150 15.400 15.510 15.499 USD -2,325 26.44 Profit of 1,642 on sale
2025-04-17 SELL -75 13.450 13.575 13.562 USD -1,017 27.12 Profit of 1,017 on sale
2025-04-15 SELL -225 13.020 13.600 13.542 USD -3,047 27.43 Profit of 3,124 on sale
2025-04-14 SELL -225 12.330 12.510 12.492 USD -2,811 27.59 Profit of 3,398 on sale
2025-04-09 SELL -300 12.500 13.070 13.013 USD -3,904 28.13 Profit of 4,536 on sale
2025-04-07 SELL -532 11.830 12.100 12.073 USD -6,423 28.51 Profit of 8,747 on sale
2025-04-04 SELL -760 11.510 13.280 13.103 USD -9,958 28.71 Profit of 11,865 on sale
2025-03-31 BUY 76 22.000 23.120 23.008 USD 1,749 29.06
2025-03-19 SELL -152 24.590 27.065 26.818 USD -4,076 29.67 Profit of 434 on sale
2025-03-14 SELL -456 25.670 26.140 26.093 USD -11,898 29.82 Profit of 1,700 on sale
2025-03-13 SELL -152 25.280 26.400 26.288 USD -3,996 29.89 Profit of 547 on sale
2025-03-12 SELL -2,584 25.190 28.505 28.173 USD -72,800 29.95 Profit of 4,601 on sale
2025-03-07 SELL -152 28.010 30.040 29.837 USD -4,535 30.06 Profit of 34 on sale
2025-03-06 SELL -228 28.130 29.110 29.012 USD -6,615 30.09 Profit of 245 on sale
2025-03-03 SELL -76 25.530 26.930 26.790 USD -2,036 30.31 Profit of 267 on sale
2025-02-28 SELL -26,226 26.170 27.060 26.971 USD -707,341 30.37 Profit of 89,265 on sale
2025-02-26 SELL -144 25.570 25.970 25.930 USD -3,734 30.52 Profit of 661 on sale
2025-02-25 SELL -432 25.080 25.380 25.350 USD -10,951 30.62 Profit of 2,276 on sale
2025-02-18 BUY 720 26.130 26.820 26.751 USD 19,261 31.02
2025-02-13 BUY 144 26.020 26.470 26.425 USD 3,805 31.34
2025-02-12 BUY 144 25.850 26.430 26.372 USD 3,798 31.45
2025-02-11 BUY 432 26.160 26.300 26.286 USD 11,356 31.56
2025-02-06 BUY 1,296 28.690 30.480 30.301 USD 39,270 31.86
2025-01-27 BUY 144 27.850 29.400 29.245 USD 4,211 32.59
2024-12-30 BUY 720 27.055 28.345 28.216 USD 20,316 33.22
2024-12-06 BUY 576 32.590 33.550 33.454 USD 19,270 33.47
2024-12-05 BUY 144 31.570 31.945 31.907 USD 4,595 33.54
2024-12-04 BUY 720 32.060 32.820 32.744 USD 23,576 33.59
2024-11-29 BUY 720 33.000 33.470 33.423 USD 24,065 33.76
2024-11-27 BUY 576 32.200 33.940 33.766 USD 19,449 33.90
2024-11-26 SELL -2,226 32.080 32.570 32.521 USD -72,392 33.98 Profit of 3,244 on sale
2024-11-25 SELL -7,110 31.980 33.000 32.898 USD -233,905 34.07 Profit of 8,357 on sale
2024-11-21 BUY 865 31.980 32.800 32.718 USD 28,301 34.28
2024-11-20 BUY 519 31.950 32.075 32.063 USD 16,640 34.41
2024-11-18 BUY 2,066 30.790 31.180 31.141 USD 64,337 34.82
2024-11-12 BUY 1,376 35.200 35.985 35.907 USD 49,407 34.79
2024-11-08 BUY 860 36.380 36.700 36.668 USD 31,534 34.68
2024-11-07 BUY 2,580 35.430 37.000 36.843 USD 95,055 34.62
2024-11-06 BUY 344 36.620 37.290 37.223 USD 12,805 34.46
2024-10-31 BUY 172 33.570 34.090 34.038 USD 5,855 34.44
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-03	SELL	-375	23.480	22.510	22.607	USD -8,478	20.95 Loss of -621 on sale
2025-12-02	BUY	150	25.655	22.950	23.221	USD 3,483	20.94
2025-11-25	SELL	-225	24.145	23.280	23.367	USD -5,257	20.84 Loss of -570 on sale
2025-11-24	SELL	-225	23.860	22.670	22.789	USD -5,128	20.82 Loss of -443 on sale
2025-11-17	SELL	-825	22.890	22.070	22.152	USD -18,275	20.78 Loss of -1,129 on sale
2025-11-12	SELL	-75	21.570	20.340	20.463	USD -1,535	20.77 Profit of 23 on sale
2025-11-06	SELL	-75	18.260	17.070	17.189	USD -1,289	20.82 Profit of 272 on sale
2025-11-05	SELL	-760	17.520	16.820	16.890	USD -12,836	20.84 Profit of 3,001 on sale
2025-11-04	SELL	-152	17.885	16.990	17.079	USD -2,596	20.86 Profit of 574 on sale
2025-11-03	SELL	-152	18.610	17.635	17.733	USD -2,695	20.87 Profit of 477 on sale
2025-10-28	BUY	228	16.420	16.620	16.600	USD 3,785	20.95
2025-10-24	SELL	-76	15.180	15.320	15.306	USD -1,163	21.01 Profit of 433 on sale
2025-10-15	BUY	456	15.620	15.810	15.791	USD 7,201	21.23
2025-10-02	BUY	76	15.000	15.620	15.558	USD 1,182	21.30
2025-09-30	BUY	150	16.220	16.370	16.355	USD 2,453	21.37
2025-08-21	SELL	-75	14.620	14.740	14.728	USD -1,105	21.56 Profit of 512 on sale
2025-07-31	BUY	225	14.260	14.790	14.737	USD 3,316	21.65
2025-06-30	SELL	-150	13.110	13.840	13.767	USD -2,065	22.70 Profit of 1,340 on sale
2025-06-25	SELL	-75	14.330	14.780	14.735	USD -1,105	22.90 Profit of 612 on sale
2025-06-20	SELL	-150	14.300	14.655	14.619	USD -2,193	23.08 Profit of 1,269 on sale
2025-05-23	BUY	75	14.210	14.310	14.300	USD 1,073	24.47
2025-05-19	SELL	-75	14.790	14.920	14.907	USD -1,118	24.81 Profit of 742 on sale
2025-05-15	SELL	-225	14.450	14.640	14.621	USD -3,290	24.99 Profit of 2,332 on sale
2025-05-12	SELL	-75	14.820	15.820	15.720	USD -1,179	25.26 Profit of 716 on sale
2025-05-09	SELL	-75	14.580	15.550	15.453	USD -1,159	25.36 Profit of 743 on sale
2025-04-30	SELL	-75	16.400	16.540	16.526	USD -1,239	26.01 Profit of 712 on sale
2025-04-24	SELL	-150	15.400	15.510	15.499	USD -2,325	26.44 Profit of 1,642 on sale
2025-04-17	SELL	-75	13.450	13.575	13.562	USD -1,017	27.12 Profit of 1,017 on sale
2025-04-15	SELL	-225	13.020	13.600	13.542	USD -3,047	27.43 Profit of 3,124 on sale
2025-04-14	SELL	-225	12.330	12.510	12.492	USD -2,811	27.59 Profit of 3,398 on sale
2025-04-09	SELL	-300	12.500	13.070	13.013	USD -3,904	28.13 Profit of 4,536 on sale
2025-04-07	SELL	-532	11.830	12.100	12.073	USD -6,423	28.51 Profit of 8,747 on sale
2025-04-04	SELL	-760	11.510	13.280	13.103	USD -9,958	28.71 Profit of 11,865 on sale
2025-03-31	BUY	76	22.000	23.120	23.008	USD 1,749	29.06
2025-03-19	SELL	-152	24.590	27.065	26.818	USD -4,076	29.67 Profit of 434 on sale
2025-03-14	SELL	-456	25.670	26.140	26.093	USD -11,898	29.82 Profit of 1,700 on sale
2025-03-13	SELL	-152	25.280	26.400	26.288	USD -3,996	29.89 Profit of 547 on sale
2025-03-12	SELL	-2,584	25.190	28.505	28.173	USD -72,800	29.95 Profit of 4,601 on sale
2025-03-07	SELL	-152	28.010	30.040	29.837	USD -4,535	30.06 Profit of 34 on sale
2025-03-06	SELL	-228	28.130	29.110	29.012	USD -6,615	30.09 Profit of 245 on sale
2025-03-03	SELL	-76	25.530	26.930	26.790	USD -2,036	30.31 Profit of 267 on sale
2025-02-28	SELL	-26,226	26.170	27.060	26.971	USD -707,341	30.37 Profit of 89,265 on sale
2025-02-26	SELL	-144	25.570	25.970	25.930	USD -3,734	30.52 Profit of 661 on sale
2025-02-25	SELL	-432	25.080	25.380	25.350	USD -10,951	30.62 Profit of 2,276 on sale
2025-02-18	BUY	720	26.130	26.820	26.751	USD 19,261	31.02
2025-02-13	BUY	144	26.020	26.470	26.425	USD 3,805	31.34
2025-02-12	BUY	144	25.850	26.430	26.372	USD 3,798	31.45
2025-02-11	BUY	432	26.160	26.300	26.286	USD 11,356	31.56
2025-02-06	BUY	1,296	28.690	30.480	30.301	USD 39,270	31.86
2025-01-27	BUY	144	27.850	29.400	29.245	USD 4,211	32.59
2024-12-30	BUY	720	27.055	28.345	28.216	USD 20,316	33.22
2024-12-06	BUY	576	32.590	33.550	33.454	USD 19,270	33.47
2024-12-05	BUY	144	31.570	31.945	31.907	USD 4,595	33.54
2024-12-04	BUY	720	32.060	32.820	32.744	USD 23,576	33.59
2024-11-29	BUY	720	33.000	33.470	33.423	USD 24,065	33.76
2024-11-27	BUY	576	32.200	33.940	33.766	USD 19,449	33.90
2024-11-26	SELL	-2,226	32.080	32.570	32.521	USD -72,392	33.98 Profit of 3,244 on sale
2024-11-25	SELL	-7,110	31.980	33.000	32.898	USD -233,905	34.07 Profit of 8,357 on sale
2024-11-21	BUY	865	31.980	32.800	32.718	USD 28,301	34.28
2024-11-20	BUY	519	31.950	32.075	32.063	USD 16,640	34.41
2024-11-18	BUY	2,066	30.790	31.180	31.141	USD 64,337	34.82
2024-11-12	BUY	1,376	35.200	35.985	35.907	USD 49,407	34.79
2024-11-08	BUY	860	36.380	36.700	36.668	USD 31,534	34.68
2024-11-07	BUY	2,580	35.430	37.000	36.843	USD 95,055	34.62
2024-11-06	BUY	344	36.620	37.290	37.223	USD 12,805	34.46
2024-10-31	BUY	172	33.570	34.090	34.038	USD 5,855	34.44

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EWTX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	151,138	0	266,759	56.7%
2025-09-18	299,086	3,699	715,954	41.8%
2025-09-17	85,673	0	187,067	45.8%
2025-09-16	107,267	0	205,730	52.1%
2025-09-15	103,285	8,072	172,990	59.7%
2025-09-12	110,533	0	154,794	71.4%
2025-09-11	210,979	9,705	313,841	67.2%
2025-09-10	83,057	286	215,101	38.6%
2025-09-09	136,813	0	242,643	56.4%
2025-09-08	178,475	800	250,273	71.3%
2025-09-05	125,435	0	296,399	42.3%
2025-09-04	110,435	0	200,421	55.1%
2025-09-03	285,589	0	509,995	56.0%
2025-09-02	138,507	0	509,980	27.2%
2025-08-29	122,360	0	254,036	48.2%
2025-08-28	739,852	0	812,279	91.1%
2025-08-27	113,992	0	277,828	41.0%
2025-08-26	600,110	0	1,695,669	35.4%
2025-08-25	147,428	0	175,881	83.8%
2025-08-22	97,199	3,000	158,897	61.2%
2025-08-21	186,801	8,916	288,590	64.7%
2025-08-20	90,423	0	112,060	80.7%
2025-08-19	168,400	0	225,305	74.7%
2025-08-18	101,427	0	142,646	71.1%
2025-08-15	71,678	0	132,129	54.2%
2025-08-14	65,874	0	119,449	55.1%
2025-08-13	65,071	0	242,949	26.8%
2025-08-12	120,620	35,365	504,422	23.9%
2025-08-11	112,383	0	165,886	67.7%
2025-08-08	88,220	0	182,998	48.2%
2025-08-07	129,711	292	209,605	61.9%
2025-08-06	91,202	14	145,015	62.9%
2025-08-05	117,358	0	203,709	57.6%
2025-08-04	133,556	0	351,254	38.0%
2025-08-01	168,174	2,682	212,557	79.1%
2025-07-31	127,977	0	171,129	74.8%
2025-07-30	228,806	275	441,915	51.8%
2025-07-29	118,810	1,021	226,399	52.5%
2025-07-28	95,917	0	204,807	46.8%
2025-07-25	173,852	0	257,272	67.6%
2025-07-24	88,412	28	140,898	62.7%
2025-07-23	86,436	24	217,266	39.8%
2025-07-22	53,712	0	75,171	71.5%
2025-07-21	44,608	0	73,911	60.4%
2025-07-18	64,350	0	89,878	71.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE